| Transaction Date | Recipient | Shares | Type | Price | Value |
|---|---|---|---|---|---|
| 23rd November 2020 | Advisors Llc Perceptive | 500,000 | Open or private purchase | $12.85 | $6,425,000.00 |
| 11th November 2020 | Ventures Iv, L.P. 5 Am | 115,504 | Open or private sale | $13.66 | $1,577,784.64 |
| 11th November 2020 | Ventures Iv, L.P. 5 Am | 27,379 | Open or private sale | $13.66 | $373,997.14 |
| 11th November 2020 | Ventures Iv, L.P. 5 Am | 657,117 | Open or private sale | $13.66 | $8,976,218.22 |
| 27th October 2020 | Advisors Llc Perceptive | 3,000,000 | Open or private purchase | $10.00 | $30,000,000.00 |
| 21st October 2020 | Advisors Llc Perceptive | 43,195 | Open or private purchase | $10.09 | $435,837.55 |
| 20th October 2020 | Capital Viii, Llc Vivo | 523,726 | Conversion of derivative | $0.00 | |
| 20th October 2020 | Capital Viii, Llc Vivo | 1,885,611 | Conversion of derivative | $0.00 | |
| 20th October 2020 | Capital Viii, Llc Vivo | 224,054 | Conversion of derivative | $0.00 | |
| 20th October 2020 | Capital Viii, Llc Vivo | 30,939 | Conversion of derivative | $0.00 |
Crinetics Pharmaceuticals
Based on disclosure changes, sentiment, insider trading and news impact we give a rating of 7/10.
Crinetics Pharmaceuticals, Inc. is a clinical stage pharmaceutical company. Its product candidate, CRN00808, is an oral nonpeptide somatostatin agonist for the treatment of acromegaly. The company was founded by R. Scott Struthers, Yun-Fei Zhu and Stephen Betz in 2008.
Ticker: CRNX
Sector: Health Technology
Industry: Pharmaceuticals: Major
SEC Central Index Key (CIK): 1658247
Employees: 68
Exchange: NASDAQ
Auditor Opinion:
You must Login to see Language Changes
Disclosure Language changes
You must Login to see analysis
Red Flags
We weren't able to import Fundamental data from the SEC disclosure.
There were no Red Flags found
Fundamentals
We weren't able to import Fundamental data from the SEC disclosure.
